Apicomplexa |
Plasmodium falciparum (Malaria) |
PfCyP19A |
XP_001351290 |
CyP highly expressed in intra-erythocytic parasites. Mature protein isolated |
[124] |
CsA K
d = 13 nM, K
i = 6.9 nM similar K
d/K
i with 11 CsA-analogs |
[124] |
[val2]CsA inhibited parasites. PSC-833 EC50 = 0.032 mM CsA = 0.32 mM |
[124, 125] |
P- glycoprotein as target molecule PfCyP19/CsA can bind to calcineurin |
PfCyP22 |
XP_001351841 |
Ibid. ER signal peptide. Mature protein isolated |
[126] |
CsA IC50 = 10 nM |
[126] |
|
|
|
PfCyP24 |
XP_001349469 |
CyP highly expressed at the late-ring parasite stage |
[127] |
|
|
Trophozoites more sensitive to CsA due to a high level of PfCyP24 expression |
[127] |
|
Toxoplasma gondii (Toxoplasmosis) |
TgCyP18 |
AAA17997 |
Mature protein isolated. Secreted. CyP binds to CCR5 receptor. Induces IL-12. Inhibits HIV infectivity by co-receptor antagonism |
[128, 129] |
CsA IC50 = 32 nM |
[128] |
T. gondii less susceptible than Plasmodium parasites. SDZ 215-918 EC50 = 0.45 mg/ml with low affinity for T. gondii CyPs |
[123] |
P- glycoprotein is likely the molecular target |
TgCyP20 |
XP_002367801 |
Mature protein isolated. N-terminal sequence with identity to calcineurin |
[128] |
CsA IC50 = 5 nM |
[128] |
|
|
|
TgFCBP57.3 |
AAX51680 |
Dual immunophilin, N-terminal FKBP and C-terminal CLD Essential for parasite survival. |
[130] |
FK506 IC50 = 70 nM CsA IC50 = 750 nM |
[130] |
|
|
|
Trypanosomatids |
Leishmania major (Cutaneous Leishmaniasis) |
LmCyP19 |
CAA73904 |
Cyps of 18, 19, 22 and 40 kDa were CsA affinity isolated. LmCyP19, the most expressed. No affinity for calcineurin |
[131, 133] |
CsA K
i = 5.2 nM |
[131] |
Extracellular L. major growth inhibition. Relatively insensitive to CsA |
[134] |
A single AA mutation in LmCyP19 fails to interact with calcineurin |
Leishmania donovani (Visceral Leishmaniasis) |
LdCyP |
AAD46565 |
CyP of the endoplasmic reticulum. Secreted to culture medium under oxidative stress |
[132] |
CsA K
d = 135 nM |
[135] |
|
[135] |
Low expression of LdCyP in the cytosol Insensitivity to CsA |
Trypanosoma brucei (Sleeping sickness) |
TbCyP19 |
AAB07896 |
Expressed and differentially transcribed Secreted protein. Cytosolic and flagellum localized |
[136] |
CsA binds TbCyP19 No inhibition experiments |
[136] |
|
|
|
Trypanosoma cruzi (Chagas´ disease) |
TcCyP19 |
AAF05985 |
TcCyP19, TcCyP22, TcCyP28 and TcCyP40 isolated by CsA affinity. TcCyP19 major cytosolic isoform, present in all parasite stages. Mitochondrial TcCyP21was identified. |
[9] |
CsA IC50 = 14 nM and H-7-94 analog IC50 = 12 nM |
[137, 138] |
Trypanocidal activity in vitro and in vivo. H-7-94 CsA analog is the most effective: TcCyP19 IC50 = 12.5 nM, T. cruzi EC50 = 0.8 mM, NIM811 is not effective |
[137] |
Besides TcCyPs also P-glycoprotein could be a molecular target |
Amebae |
Entamoeba histolytica (Enteric diseases) |
EhCyp |
AAB86601 |
60 to 70% sequence identity with the other cyclophilins. Transcribed and expressed. |
[139] |
PPIase Inhibition with CsA at nM concentration |
[139] |
CsA EC50 at 1–10 mg/ml on thophozoites |
[139, 140] |
Interference the activity of calcineurin and P-gP |
Flagellates |
Giardia intestinalis (Enteric diseases) |
GiCyP1 |
XP_001707838 |
Found as a single gene. Similar to EhCyP and hCyP18 |
[141] |
Total PPIase Inhibition with 500 nM CsA |
[141] |
|
|
|
Coccidia |
Cryptosporidium parvum (Cryptosporidiosis) |
|
|
|
|
|
|
CsA EC50 at 1.5 mM and IC50 of 1 mM for PSC-833 derivative |
[142] |
CsA inhibits CnA PSC-833 binds to P-glycoprotein |
For comparison |
Homo sapiens
|
hCyPA |
CAA37039 |
Cyclophilin like domain characteristics in the text. |
|
CsA IC50 = 20 nM, NIM811 K
i = 2.1 nM, Debio-025 K
i = 0.34 nM H-7-94 IC50 = 70 nM PSC-833 does not bind hCyPA |
[8, 9, 137, 143] |
|
|
|